Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy

European Journal of Heart Failure
G F MuredduPREDICTOR Study Group

Abstract

We conducted a population-based cross-sectional study to assess the prevalence of both preclinical and clinical heart failure (HF) in the elderly. A sample of 2001 subjects, 65- to 84-year-old residents in the Lazio Region (Italy), underwent physical examination, biochemistry/N-terminal pro brain natriuretic peptide (NT-proBNP) assessment, electrocardiography, and echocardiography. Systolic left ventricular dysfunction (LVD) was defined as left ventricular ejection fraction (LVEF) <50%. Diastolic LVD was defined by a Doppler-derived multiparametric algorithm. The overall prevalence of HF was 6.7% [95% confidence interval (CI) 5.6-7.9], mainly due to HF with preserved LVEF (HFpEF) (4.9%; 95% CI 4.0-5.9), and did not differ by gender. A systolic asymptomatic LVD (ALVD) was detected more frequently in men (1.8%; 95% CI 1.0-2.7) than in women (0.5%; 95% CI 0.1-1.0; P = 0.005), whereas the prevalence of diastolic ALVD was comparable between genders (men: 35.8%; 95% CI = 32.7-38.9; women: 35.0%; 95% CI = 31.9-38.2). The NT-proBNP levels and severity of LVD increased with age. Overall, 1623 subjects (81.1% of the entire studied population) had preclinical HF (Stage A: 22.2% and stage B: 59.1% respectively). A large number of subjects ...Continue Reading

References

Sep 1, 1989·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·N B SchillerI Schnittger
Apr 23, 1999·European Heart Journal·M R CowieG C Sutton
Aug 9, 2002·European Journal of Heart Failure·Fátima CeiaUNKNOWN EPICA Investigators
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer
Jul 25, 2003·American Journal of Hypertension·Paolo VerdecchiaGiuseppe Ambrosio
Aug 13, 2003·Circulation·Thomas J WangRamachandran S Vasan
Aug 18, 2004·Journal of Hypertension·Philippe GosseRoland Schmieder
May 20, 2005·European Heart Journal·Karl SwedbergUNKNOWN Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Sep 20, 2005·Journal of the American College of Cardiology·Sharon Ann HuntUNKNOWN American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evalua
Feb 7, 2006·Journal of the American College of Cardiology·Jae K OhWilliam C Little
Feb 7, 2006·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Roberto M LangUNKNOWN European Association of Echocardiography, European Society of Cardiology
Feb 24, 2006·The Medical Journal of Australia·Walter P AbhayaratnaDarryl A McGill
Nov 9, 2006·JAMA : the Journal of the American Medical Association·Francesca BursiVéronique L Roger
Jan 17, 2009·European Journal of Heart Failure·Alessandro BoccanelliUNKNOWN AREA IN-CHF Investigators
Oct 8, 2009·Circulation. Heart Failure·Tatiana KuznetsovaJan A Staessen
May 25, 2010·European Journal of Heart Failure·Alon BarsheshetUNKNOWN HFSIS Steering Committee and Investigators
Nov 29, 2011·European Journal of Heart Failure·Gnanadevan MahadevanMichael Frenneaux

❮ Previous
Next ❯

Citations

Oct 3, 2012·The Annals of Occupational Hygiene·Peter BrandThomas Kraus
Aug 25, 2012·Cardiology Research and Practice·Z N Sohani, Z Samaan
Sep 14, 2014·Progress in Cardiovascular Diseases·Nidhi MehtaJames N Kirkpatrick
Jul 2, 2014·Current Heart Failure Reports·Gülmisal Güder, Frans H Rutten
Jul 16, 2013·Lancet·Francesco Forastiere, Nera Agabiti
Jan 28, 2014·European Journal of Heart Failure·Narjes Saheb Sharif-AskariArif Abdullatif Al-Mulla
Jan 5, 2013·European Journal of Heart Failure·Arno W Hoes
May 17, 2012·European Journal of Heart Failure·Justin A Ezekowitz
Feb 26, 2013·European Journal of Heart Failure·Elisabeth Kraigher-KrainerRamachandran S Vasan
Jan 17, 2013·European Journal of Heart Failure·Elena KamychevaRolf Jorde
Mar 14, 2014·Journal of Internal Medicine·S MassonUNKNOWN Investigators of the PREDICTOR study
Sep 19, 2015·JACC. Cardiovascular Imaging·Frank A FlachskampfOtto A Smiseth
Dec 3, 2013·Journal of the American College of Cardiology·Siu-Hin WanHorng H Chen
Nov 1, 2013·Journal of the Saudi Heart Association·Abdullah M AlshehriAdel Youssef
Aug 3, 2016·International Journal of Environmental Research and Public Health·Liang GuoYingxian Sun
Jun 3, 2018·Journal of the American Heart Association·Matthew NayorRamachandran S Vasan
May 4, 2017·Journal of the American Heart Association·Lotte JacobsUNKNOWN Heart “OMics” in AGEing (HOMAGE) investigators
May 26, 2017·The European Respiratory Journal·Nera Agabiti, Giuseppe Maria Corbo
Oct 15, 2013·Allergy·S S PanesarUNKNOWN EAACI Food Allergy and Anaphylaxis Group
Oct 2, 2019·Echocardiography·Ahmed AbuzaidNelson B Schiller
Nov 2, 2013·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Silvio V BertoliFarina Stefania
May 21, 2019·Circulation. Heart Failure·João Pedro FerreiraFaiez Zannad
Jul 28, 2019·ESC Heart Failure·Mitja LainscakJerneja Farkas
Sep 8, 2016·Journal of Cardiovascular Development and Disease·George E Louridas, Katerina G Lourida
Oct 12, 2019·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Theodora NikolaidouAndrew L Clark
Jun 12, 2020·European Heart Journal Supplements : Journal of the European Society of Cardiology·Alessandro Boccanelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.